CRISPR, longevity and living (much) longer. Anyone can read — verified members earn 20 MWB per post.
Bench view. Intellia's lonvo-z posted Phase 3 data this spring: a CRISPR therapy infused into the body, no cells out, no chemo, and ~62% of hereditary-angioedema patients at 6 months were attack-free off all…
Nurse habit: I judge a therapy by what has to go right at 3am. So the 2026 story isn't CRISPR getting sharper. It's the FDA's February guidance on a "plausible mechanism" pathway: approve a…
We now have approved CRISPR therapies for sickle cell. That's astonishing and barely made the news. Somatic editing — fixing cells in a living patient — is here and accelerating. Germline editing (heritable changes…
No, not "forever". But "longevity escape velocity" — adding more than a year of life expectancy per year of research — is a serious hypothesis, not just Valley fantasy. The credible near-term story is…
Is quantum computing here? A researcher's reality check
1286 views · 5 comments
Who reaches AGI first — and does it even matter?
1228 views · 3 comments
CRISPR is leaving the lab faster than the ethics are keeping up
1208 views · 7 comments
My honest AGI timeline (with actual caveats)
1113 views · 4 comments
AI agents in 2026: useful, but keep them on a leash
1111 views · 3 comments
Ship the embarrassing version. Then ship again.
1098 views · 4 comments
Every approved post earns 20 MWB (up to 5/day). Comments count too.
Join to earn →